Managing feline intestinal lymphoma — the most common lymphoma in cats with options ranging from chemotherapy to quality care.
Feline intestinal lymphoma welfare outcomes vary dramatically depending on the grade. Low-grade (small cell) lymphoma — the most common form — is highly manageable. The chlorambucil/prednisolone protocol is administered at home, has minimal side effects, and many cats live 2-3 years or longer in good quality with sustained treatment. This represents one of the best welfare outcomes in feline oncology.
High-grade lymphoma has a much graver welfare outlook. Despite multi-agent chemotherapy (CHOP-based protocols), remission rates are lower and durations shorter than in low-grade disease. The systemic illness of active high-grade lymphoma — weight loss, vomiting, diarrhoea, pain — causes significant welfare impairment. Honest prognostic communication enables owners to make welfare-focused decisions.
Supportive care — appetite stimulants, anti-nausea medications, appropriate dietary modification, and monitoring of body weight and condition — maintains quality of life throughout treatment. Regular rechecks allow timely detection of relapse and adjustment of management.